scholarly article | Q13442814 |
P356 | DOI | 10.1007/S13277-016-5245-1 |
P698 | PubMed publication ID | 27465552 |
P2093 | author name string | Qing Liu | |
Xia Zhang | |||
Qian Chen | |||
Yan Liang | |||
Xue Liu | |||
Xiu-Wu Bian | |||
Xi-Long Zhao | |||
Xian-Chao Zhang | |||
Yi-Fang Ping | |||
Xu-Gang Hu | |||
Ti-Wei Fu | |||
P2860 | cites work | Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines | Q24290329 |
Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin | Q24313509 | ||
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature | Q24652514 | ||
Breast cancer intrinsic subtype classification, clinical use and future trends | Q26773761 | ||
Epithelial-mesenchymal transition in gastric cancer | Q26775029 | ||
Cancer statistics, 2015 | Q27860576 | ||
Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
The functions and regulation of the PTEN tumour suppressor | Q29615536 | ||
Sox2 promotes tamoxifen resistance in breast cancer cells | Q34381786 | ||
Tackling the cancer stem cells - what challenges do they pose? | Q34523263 | ||
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis | Q34607187 | ||
Hypoxia and the extracellular matrix: drivers of tumour metastasis | Q34820282 | ||
The two faces of PTP1B in cancer | Q35005347 | ||
Emerging strategies for treating brain metastases from breast cancer | Q35075446 | ||
FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer | Q35180874 | ||
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms | Q35204583 | ||
Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients | Q35565061 | ||
Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction | Q35606400 | ||
A small-molecule inhibitor suppresses the tumor-associated mitochondrial NAD(P)+-dependent malic enzyme (ME2) and induces cellular senescence | Q35640870 | ||
Targeting and limiting surgery for patients with node-positive breast cancer | Q35673614 | ||
Leptin and insulin act on POMC neurons to promote the browning of white fat. | Q35676283 | ||
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice | Q35698954 | ||
Oncogenic extracellular HSP70 disrupts the gap-junctional coupling between capillary cells | Q35832975 | ||
Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways | Q35868202 | ||
Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells | Q35879903 | ||
14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB Pathway | Q35885159 | ||
Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer | Q35977527 | ||
Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma | Q36092648 | ||
Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population | Q36471425 | ||
Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway | Q36544237 | ||
Primary tumor- and metastasis-derived colon cancer cells differently modulate connexin expression and function in human capillary endothelial cells | Q36557140 | ||
ALDH1A1 mRNA expression in association with prognosis of triple-negative breast cancer | Q36562382 | ||
Requirement for interaction of PI3-kinase p110α with RAS in lung tumor maintenance | Q37303694 | ||
PTP1B expression is an independent positive prognostic factor in human breast cancer | Q37377170 | ||
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts | Q37564312 | ||
Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy | Q37740954 | ||
Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets | Q38107451 | ||
Cancer stem cells and their vascular niche: Do they benefit from each other? | Q38483195 | ||
Protein Tyrosine Phosphatases in Hypothalamic Insulin and Leptin Signaling | Q38598883 | ||
The PI3K/AKT Pathway as a Target for Cancer Treatment | Q38608907 | ||
Breast cancer stem cells: are we ready to go from bench to bedside? | Q38696803 | ||
Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment? | Q38704653 | ||
Rab11-FIP2 promotes colorectal cancer migration and invasion by regulating PI3K/AKT/MMP7 signaling pathway. | Q38801189 | ||
miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma | Q38869719 | ||
SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network | Q39173044 | ||
Effects of estrogen on the proportion of stem cells in the breast. | Q39652970 | ||
HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline | Q39983856 | ||
ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer. | Q41674321 | ||
Identification of Bidentate Salicylic Acid Inhibitors of PTP1B. | Q43242949 | ||
Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis | Q48924768 | ||
Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1. | Q53226116 | ||
Expression patterns of stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic factors in invasive ductal carcinoma of the breast. | Q53276495 | ||
Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. | Q53335960 | ||
Interrogating Endogenous Protein Phosphatase Activity with Rationally Designed Chemosensors. | Q54233465 | ||
American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. | Q55154696 | ||
SnapShot: The epithelial-mesenchymal transition | Q83767418 | ||
P433 | issue | 10 | |
P304 | page(s) | 13479-13487 | |
P577 | publication date | 2016-07-27 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT. | |
P478 | volume | 37 |
Q96946545 | Activation of tyrosine phosphatase PTP1B in pyramidal neurons impairs endocannabinoid signaling by tyrosine receptor kinase trkB and causes schizophrenia-like behaviors in mice |
Q58695806 | NKX2-1-AS1 negatively regulates CD274/PD-L1, cell-cell interaction genes, and limits human lung carcinoma cell migration |
Q55262820 | Protection against gamma-radiation injury by protein tyrosine phosphatase 1B. |
Q60307276 | Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2 |
Q64262684 | miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma |
Search more.